Literature DB >> 10052594

N-glycan structures of a recombinant mouse soluble Fcgamma receptor II.

N Takahashi1, W Yamada, K Masuda, H Araki, Y Tsukamoto, A Galinha, C Sautès, K Kato, I Shimada.   

Abstract

N-glycans of a recombinant mouse soluble Fcgamma receptor II (sFcgammaRII) expressed in baby hamster kidney cells were released from glycopeptides by digestion with glycoamidase A (from sweet almond), and the reducing ends of the oligosaccharides were reductively aminated with 2-aminopyridine. The derivatized N-glycans were separated and structurally identified by a three-dimensional high-performance liquid chromatography (HPLC) mapping technique on three kinds of HPLC columns [Takahashi, et al. (1995) Anal. Biochem. 226:139-46]. Eighteen different major N-glycan structures were identified, of which six were neutral (45%), five mono-sialyl (49%), one di-sialyl (4.6%), five tri-sialyl (1.1%), and one tetra-sialyl (0.3%). All N-glycan structures determined were complex type with fucosylation at the N-acetylglucosamine residue of the reducing end, and N-acetylneuraminic acid, when present, was alpha-(2,3)-linked. The existence of a unique structure containing both N-acetylgalactosamine and alpha-(2,3)-N-acetylneuraminic acid residues at the reducing ends, as below, was confirmed by MALDI-TOF mass spectrometry. Carbohydrate sequence [see text]

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10052594     DOI: 10.1023/a:1006915200989

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  23 in total

Review 1.  Soluble Fc gamma receptors: interaction with ligands and biological consequences.

Authors:  J Galon; P Paulet; A Galinha; P Lorès; C Bonnerot; J Jami; W H Fridman; C Sautès
Journal:  Int Rev Immunol       Date:  1997       Impact factor: 5.311

2.  Demonstration of a new amidase acting on glycopeptides.

Authors:  N Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1977-06-20       Impact factor: 3.575

3.  Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro.

Authors:  N Varin; C Sautès; A Galinha; J Even; P M Hogarth; W H Fridman
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

4.  Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique.

Authors:  H Nakagawa; M Zheng; S Hakomori; Y Tsukamoto; Y Kawamura; N Takahashi
Journal:  Eur J Biochem       Date:  1996-04-01

5.  Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.

Authors:  J C Edberg; R P Kimberly
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

6.  Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell line HBL-38.

Authors:  S Yamamoto; S Hase; S Fukuda; O Sano; T Ikenaka
Journal:  J Biochem       Date:  1989-04       Impact factor: 3.387

7.  Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides.

Authors:  N Takahashi; H Nakagawa; K Fujikawa; Y Kawamura; N Tomiya
Journal:  Anal Biochem       Date:  1995-03-20       Impact factor: 3.365

8.  Two-dimensional elution map of GalNAc-containing N-linked oligosaccharides.

Authors:  N Takahashi; Y Wada; J Awaya; M Kurono; N Tomiya
Journal:  Anal Biochem       Date:  1993-01       Impact factor: 3.365

Review 9.  Natural and recombinant soluble low-affinity Fc gamma R: detection, purification, and functional activities.

Authors:  J L Teillaud; C Bouchard; A Astier; C Teillaud; E Tartour; J Michon; A Galinha; J Moncuit; N Mazières; R Spagnoli
Journal:  Immunomethods       Date:  1994-02

10.  Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens.

Authors:  M E Esposito-Farese; C Sautès; H de la Salle; S Latour; T Bieber; C de la Salle; P Ohlmann; W H Fridman; J P Cazenave; J L Teillaud
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

View more
  4 in total

1.  Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.

Authors:  Jerrard M Hayes; Asa Frostell; Robert Karlsson; Steffen Müller; Silvia Míllan Martín; Martin Pauers; Franziska Reuss; Eoin F Cosgrave; Cecilia Anneren; Gavin P Davey; Pauline M Rudd
Journal:  Mol Cell Proteomics       Date:  2017-06-02       Impact factor: 5.911

2.  Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Authors:  Albert Lee; Joel M Chick; Daniel Kolarich; Paul A Haynes; Graham R Robertson; Maria Tsoli; Lucy Jankova; Stephen J Clarke; Nicolle H Packer; Mark S Baker
Journal:  Mol Cell Proteomics       Date:  2010-02-18       Impact factor: 5.911

Review 3.  Fc gamma receptors: glycobiology and therapeutic prospects.

Authors:  Jerrard M Hayes; Mark R Wormald; Pauline M Rudd; Gavin P Davey
Journal:  J Inflamm Res       Date:  2016-11-16

4.  Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum.

Authors:  Hirokazu Yagi; Daisuke Takakura; Lubka T Roumenina; Wolf Herman Fridman; Catherine Sautès-Fridman; Nana Kawasaki; Koichi Kato
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.